Try our clinical trial finder
Getting started with the Colorectal Cancer Alliance Clinical Trial Finder is easy! Answering a simple series of questions allows us to find relevant trials that fit your needs.
Let's get started
After completing the questions below, you will be presented with your personalized results.
If no trials are available, then our system will continue to search and alert you if a match is made.
Up Next
More about clinical trialsTop resources
![A sign at the BMS headquarters](/sites/default/files/styles/450x250/public/media/images/bms-sign-1920.png.webp?itok=qtRzhXHJ)
Krazati approved for previously treated KRASG12C colorectal cancer
The treatment option is for patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC) who have received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
![Christy Williams, a mom and colorectal cancer survivor, plays a table-top game with her family.](/sites/default/files/styles/450x250/public/media/images/christy-3.png.webp?itok=DxDhUqH-)
Christy Williams: Biomarker testing leads to successful treatment
Statistics suggested that Christy’s odds of survival were grim, so she leaned into her faith and kept a positive outlook. She tried to control what she could. And, critically, she received biomarker testing.
![An image of the exterior of the U.S. Capitol Building](/sites/default/files/styles/450x250/public/media/images/us-capitol.png.webp?itok=_OXI0Lld)
EPIC Act to Advance New CRC Therapies Needs Support
The EPIC Act would encourage investment in clinical trials for additional uses of existing drugs.